![photo of medical researcher](https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/article_thumbnails/slideshows/latest_crohns_disease_research_sends_message_of_hope_slideshow/1800x1200_latest_crohns_disease_research_sends_message_of_hope_slideshow.jpg)
The drug ublituximab beat a standard oral medication for MS in reducing patients' relapses and proved better at preventing areas of inflammatory damage in the brain.
from WebMD Health https://ift.tt/HRDxgy1
The drug ublituximab beat a standard oral medication for MS in reducing patients' relapses and proved better at preventing areas of inflammatory damage in the brain.
0 comments:
Post a Comment